Phase 2 Study of the MEK inhibitor MEKTOVI (binimetinib) for the treatment of pediatric adamantinomatous craniopharyngioma
Details
Age
Child to Adult
Type of Study
Treatment
Locations
Childrens Hospital Colorado
Principal Investigator
Kathleen Dorris, MD
Study ID
Protocol Number: 22-2133
More information available at ClinicalTrials.gov: NCT05286788
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers